Fitch also affirmed JSMC’s $60.1 million of series 2006 bonds.
The outlook remains negative.
The rating assignment, rating affirmation and negative outlook are based on several factors, including JSMC’s ongoing negative operating performance, improved debt burden and adequate liquidity.
More articles on healthcare finance:
How to overcome 3 major hurdles to surgical bundle success
Moody’s: Children’s hospitals see stronger financials than adult hospitals in FY 2015
More indigent care provided at UNMH than funds can cover, audit finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
